What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review

BACKGROUND: Granulomatous disease is reported in at least 8–20% of patients with common variable immunodeficiency (CVID). Granulomatous disease mainly affects the lungs, and is associated with significantly higher morbidity and mortality. In half of patients with granulomatous disease, extrapulmonar...

Descripción completa

Detalles Bibliográficos
Autores principales: van Stigt, Astrid C., Dik, Willem A., Kamphuis, Lieke S. J., Smits, Bas M., van Montfrans, Joris M., van Hagen, P. Martin, Dalm, Virgil A. S. H., IJspeert, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773704/
https://www.ncbi.nlm.nih.gov/pubmed/33391274
http://dx.doi.org/10.3389/fimmu.2020.606389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773704/
https://www.ncbi.nlm.nih.gov/pubmed/33391274
http://dx.doi.org/10.3389/fimmu.2020.606389

Ejemplares similares